Edesa Biotech Publishes Phase 2 Substudy Results of ARDS Drug Candidate

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/12/2026

1. ORCL
2. ADBE
3. RH
4. SPY
5. CPRT
6. ACVA
7. SEDG
8. SPCX
9. TLT
10. PMTS

Go back to Edesa Biotech Publishes Phase 2 Substudy Results of ARDS Drug Candidate
(NASDAQ: EDSA) Delayed: 4.23 -0.43 (9.23%)
Previous Close $4.66    52 Week High $ 
Open $4.70    52 Week Low $ 
Day High $4.84    P/E N/A 
Day Low $4.23    EPS $ 
Volume 26,785